Table 1.
Protein | Regulated pathway | Phenotype | Isoform | Reference |
---|---|---|---|---|
Tiam1 | Rac pathway | Rac1 inactivation | Nm23-H1 | [68] |
Ksr | Erk pathway | Ksr degradation | Nm23-H1 | [11] |
Rps3 | Erk pathway | Ark pathway inactivation | Nm23-H1 | [69] |
Lbc | Rho GTPase pathway | Rho GTPase pathway inhibition | Nm23-H2 | [70] |
Rad | Ras pathway | Ras pathway inactivation | Nm23-H1 | [71] |
Dbl-1 | cdc42 | Cdc42 GTPase inhibition | Nm23-H1 | [72] |
ARF6 | Endocytosis | E-cadherin-mediated edocytosis | Nm23-H1 | [73] |
STRAP | TGFβ pathway | p53-induced apoaptosis and cell cycle arrest | Nm23-H1 | [74] |
EBNA-1-3C | Transcriptional regulation | Increased MMP9 and αV integrin expression | Nm23-H1 | [20] |
ERα | Transcriptional regulation | Reduced cathepsin and Bcl-2 expression | Nm23-H1 | [75] |
ERβ | Transcriptional regulation | Increased estrogen-mediated transcription | Nm23-H2 | [76] |
RORaa | Transcriptional regulation | N/A | Nm23-H1, Nm23-H2 | [77] |
Oct-1 | Transcriptional regulation | N/A | Nm23-H1 | [78] |
SET | Transcriptional regulation | Granzyme A-mediated cell death | Nm23-H1 | [79] |
Vimentin | Cytoskeleton modulation | Increased intermediate filaments density | Nm23-H1 | [80] |
Tubulin | Cytoskeleton modulation | N/A | Nm23-H1 | [81] |
Icap-1a | Cell adhesion | N/A | Nm23-H2 | [82] |
Plakoglobin | Cell adhesion | Increased protein stability | Nm23-H1, Nm23-H2 | [83] |
APE1 | DNA repair | Increased APE1 endonuclease activity | Nm23-H1 | [15] |
Prune | Pro-metastasis | Increase cAMP-PDE prune activity | Nm23-H1 | [84] |
MDM2 | p53 degradation | Inhibition Nm23 anti-motility ability | Nm23-H2 | [85] |
HPV 16E7 | Cervical cancer | Ubiquitin-proteosome-dependent Nm23 degradation | Nm23-H1, Nm23-H2 | [86] |
GAPDH | Glycolytic pathway | Phosphoglycerate mutase activation | Nm23-H1 | [87] |
Aurora-A | Mitosis | N/A | Nm23-H1 | [88] |
The interaction has been shown only by two-hybrid and GST pull down experiments